ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Monetary incentives and peer referral in promoting secondary distribution of HIV self-testing among men who have sex with men in China: A randomized controlled trial

Zhou, Yi Y.; Lu, Ying; Ni, Yuxin; Wu, Dan; He, Xi; Ong, Jason; Tucker, Joseph; Sylvia, Sean; Jing, Fengshi; Li, Xiaofeng; Huang, Shanzi; Shen, Guangquan; Xu, Chen; Xiong, Yuan; Sha, Yongjie; Cheng, Mengyuan; Xu, Junjie; Jiang, Hongbo; Dai, Wencan; Huang, Liqun; Zou, Fei; Wang, Cheng; Yang, Bin; Mei, Wenhua; Tang, Weiming*广东药学院; 中国医科大学
PLoS Medicine2022-2DOI: 10.1371/journal.pmed.1003928
10被引18阅读
引用收藏
分享

摘要

Background @@@ Digital network-based methods may enhance peer distribution of HIV self-testing (HIVST) kits, but interventions that can optimize this approach are needed. We aimed to assess whether monetary incentives and peer referral could improve a secondary distribution program for HIVST among men who have sex with men (MSM) in China. @@@ Methods and findings @@@ Between October 21, 2019 and September 14, 2020, a 3-arm randomized controlled, single-blinded trial was conducted online among 309 individuals (defined as index participants) who were assigned male at birth, aged 18 years or older, ever had male-to-male sex, willing to order HIVST kits online, and consented to take surveys online. We randomly assigned index participants into one of the 3 arms: (1) standard secondary distribution (control) group (n = 102); (2) secondary distribution with monetary incentives (SD-M) group (n = 103); and (3) secondary distribution with monetary incentives plus peer referral (SD-M-PR) group (n = 104). Index participants in 3 groups were encouraged to order HIVST kits online and distribute to members within their social networks. Members who received kits directly from index participants or through peer referral links from index MSM were defined as alters. Index participants in the 2 intervention groups could receive a fixed incentive ($3 USD) online for the verified test result uploaded to the digital platform by each unique alter. Index participants in the SD-M-PR group could additionally have a personalized peer referral link for alters to order kits online. Both index participants and alters needed to pay a refundable deposit ($15 USD) for ordering a kit. All index participants were assigned an online 3-month follow-up survey after ordering kits. The primary outcomes were the mean number of alters motivated by index participants in each arm and the mean number of newly tested alters motivated by index participants in each arm. These were assessed using zero-inflated negative binomial regression to determine the group differences in the mean number of alters and the mean number of newly tested alters motivated by index participants. Analyses were performed on an intention-to-treat basis. We also conducted an economic evaluation using microcosting from a health provider perspective with a 3-month time horizon. The mean number of unique tested alters motivated by index participants was 0.57 +/- 0.96 (mean +/- standard deviation [SD]) in the control group, compared with 0.98 +/- 1.38 in the SD-M group (mean difference [MD] = 0.41),and 1.78 +/- 2.05 in the SD-M-PR group (MD = 1.21). The mean number of newly tested alters motivated by index participants was 0.16 +/- 0.39 (mean +/- SD) in the control group, compared with 0.41 +/- 0.73 in the SD-M group (MD = 0.25) and 0.57 +/- 0.91 in the SD-M-PR group (MD = 0.41), respectively. Results indicated that index participants in intervention arms were more likely to motivate unique tested alters (control versus SD-M: incidence rate ratio [IRR = 2.98, 95% CI = 1.82 to 4.89, p-value < 0.001; control versus SD-M-PR: IRR = 3.26, 95% CI = 2.29 to 4.63, p-value < 0.001) and newly tested alters (control versus SD-M: IRR = 4.22, 95% CI = 1.93 to 9.23, p-value < 0.001; control versus SD-M-PR: IRR = 3.49, 95% CI = 1.92 to 6.37, p-value < 0.001) to conduct HIVST. The proportion of newly tested testers among alters was 28% in the control group, 42% in the SD-M group, and 32% in the SD-M-PR group. A total of 18 testers (3 index participants and 15 alters) tested as HIV positive, and the HIV reactive rates for alters were similar between the 3 groups. The total costs were $19,485.97 for 794 testers, including 450 index participants and 344 alter testers. Overall, the average cost per tester was $24.54, and the average cost per alter tester was $56.65. @@@ Monetary incentives alone (SD-M group) were more cost-effective than monetary incentives with peer referral (SD-M-PR group) on average in terms of alters tested and newly tested alters, despite SD-M-PR having larger effects. Compared to the control group, the cost for one more alter tester in the SD-M group was $14.90 and $16.61 in the SD-M-PR group. For newly tested alters, the cost of one more alter in the SD-M group was $24.65 and $49.07 in the SD-M-PR group. No study-related adverse events were reported during the study. Limitations include the digital network approach might neglect individuals who lack internet access. @@@ Conclusions @@@ Monetary incentives alone and the combined intervention of monetary incentives and peer referral can promote the secondary distribution of HIVST among MSM. Monetary incentives can also expand HIV testing by encouraging first-time testing through secondary distribution by MSM. This social network-based digital approach can be expanded to other public health research, especially in the era of the Coronavirus Disease 2019 (COVID-19)

学科与关键词

关键词
FINANCIAL INCENTIVESCARE3-ARMWOMEN
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PLoS Medicine
发表日期
2022-02
卷期
第 19 卷, 第 2 期
页码
e1003928
DOI
10.1371/journal.pmed.1003928
语言
ENGLISH
期刊等级
1区
成果收录
SSCI · SCIE
资助标注
National Nature Science Foundation of China [81903371]; National Key Research and Development Program of China [2017YFE0103800]; Academy of Medical Sciences; Newton Fund [NIF\R1\181020]; National Institutes of Health [R34MH119963, R25 AI140495]; Zhuhai Medical and Health Science and Technology Plan Project [20181117A010064]

作者

  • Z

    Zhou, Yi Y. (第一作者)

  • L

    Lu, Ying

查看全部 25 位作者收起作者
  • N

    Ni, Yuxin

  • W

    Wu, Dan

  • H

    He, Xi

  • O

    Ong, Jason

  • T

    Tucker, Joseph

  • S

    Sylvia, Sean

  • J

    Jing, Fengshi

  • L

    Li, Xiaofeng

  • H

    Huang, Shanzi

  • S

    Shen, Guangquan

  • X

    Xu, Chen

  • X

    Xiong, Yuan

  • S

    Sha, Yongjie

  • C

    Cheng, Mengyuan

  • X

    Xu, Junjie

    china med univ

  • J

    Jiang, Hongbo

    guangdong pharmaceut univ

  • D

    Dai, Wencan

  • H

    Huang, Liqun

  • Z

    Zou, Fei

  • W

    Wang, Cheng

  • Y

    Yang, Bin

  • M

    Mei, Wenhua

  • T

    Tang, Weiming (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417